Allergic rhinitis in children: incidence and treatment in Dutch general practice in 1987 and 2001
Related Experiment Video
Updated: Jun 27, 2026

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Cindy M A de Bot1, Heleen Moed, François G Schellevis
1Department of General Practice, Erasmus MC - University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands. c.debot@erasmusmc.nl
Insights
The incidence of allergic rhinitis in children increased in Dutch general practice between 1987 and 2001. Treatment aligned with guidelines, with a shift towards oral antihistamines in 2001.
Area of Science:
- Pediatric Health
- Epidemiology
- General Practice
Background:
- Allergic rhinitis is a prevalent chronic condition in children, frequently managed in primary care settings.
- Understanding trends in incidence and treatment is crucial for effective pediatric healthcare strategies.
Purpose of the Study:
- To investigate the national incidence and treatment patterns of allergic rhinitis in Dutch children (0-17 years) in 1987 and 2001.
- To identify changes in incidence rates and general practitioner management over time.
Main Methods:
- Comparative analysis of data from the first (1987) and second (2001) Dutch national surveys of general practice.
- Incidence rates were analyzed by age, sex, urbanization, and season.
- Drug prescriptions and specialist referrals were assessed against the 1996 clinical guideline.
Main Results:
- Allergic rhinitis incidence rose from 6.6 to 9.2 per 1000 person-years.
- A male predominance shifted to female predominance in adolescence; incidence increased in rural/suburban areas and central Netherlands.
- Treatment showed stronger adherence to the 1996 guideline in 2001, with a shift from nasal corticosteroids to oral antihistamines.
Conclusions:
- The incidence of allergic rhinitis in children has increased in Dutch general practice over the studied period.
- Treatment management by general practitioners has improved and aligned more closely with clinical guidelines.
- The observed shift in prescription patterns may reflect the impact of the 1996 clinical guideline.
Abstract:
Allergic rhinitis is a common chronic disorder in children, mostly diagnosed in primary health care. This study investigated the national incidence and treatment of allergic rhinitis among children aged 0-17 yr in Dutch general practice in 1987 and 2001 to establish whether changes have occurred. A comparison was made with data from the first (1987) and second (2001) Dutch national surveys of general practice on children aged 0-17 yr. Incidence rates were compared by age, sex, level of urbanization and season. The management of the general practitioner was assessed regarding drug prescriptions and referrals to medical specialists, and compared with the clinical guideline issued in 1996. The incidence rate of allergic rhinitis increased from 6.6 (1987) to 9.2 (2001) per 1000 person-years. We found a male predominance with a switch in adolescence to a female predominance at both time points. The increase in incidence was the highest in rural (<30,000 inhabitants) and suburban areas (30,000-50,000 inhabitants). Compared to 1987, there was a significant increase in incidence in the central part of the Netherlands in 2001. In both years, the incidence was higher in spring compared with the other seasons. In 2001, children of natives and western immigrants visited the general practitioner more often with complaints of allergic rhinitis compared to 1987. In 1987, prescribed medication consisted mainly of nasal corticosteroids (36%) and in 2001 of oral antihistamines (45%). Although a clinical guideline was not issued until 1996, overall, the treatment of allergic rhinitis by general practitioners was in both years in accordance with the current clinical guideline, but with a stronger adherence in 2001. The results show an increased incidence in the past decades of allergic rhinitis in children in Dutch general practice. The shift to a smaller spectrum of prescriptions in 2001 may be a result of the 1996 clinical guideline.
Related Concept Videos
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Allergic Reactions: Anaphylaxis
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Allergic Reactions
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma I: Introduction
